Mortality (all infants): 0.2 mg IM versus 0.5 mg IM · preterm infants
Higher dose vitamin K showed no clear difference in mortality (all infants): 0.2 mg IM versus 0.5 mg IM compared with lower dose vitamin K (low certainty).
1 finding from 1 review
The proportion of pressure ulcers healed · nursing home patients, > 59 years old
Water mattress overlay showed no clear difference in pressure ulcer healing compared with low‐tech mattress (low certainty).
1 finding from 1 review
All‐cause mortality Study duration range 12‐96 months Omega‐6 dose range 1.5%‐24.5% E · adults with or without existing CVD
Higher showed no clear difference in all‐cause mortality Study duration range 12‐96 months Omega‐6 dose… compared with lower omega‐6: primary outcomes (low certainty).
1 finding from 1 review
LDL Study duration range 12‐24 months Omega‐6 dose range 2.0%‐15.0% E · adults with or without existing CVD
1 finding from 1 review
HDL Study duration range 12‐24 months Omega‐6 dose range 2.0%‐15.0% E · adults with or without existing CVD
1 finding from 1 review
Weight (kg) · adults with or without existing CVD
1 finding from 1 review
Body‐mass index (BMI) · adults with or without existing CVD
1 finding from 1 review
Cardiovascular mortality · adults with or without existing CVD
It is very uncertain whether higher changes cardiovascular mortality Study duration range 24‐96 months Omega‐6… compared with lower omega‐6: primary outcomes (very low certainty).
1 finding from 1 review
Cardiovascular events · adults with or without existing CVD
Higher showed no clear difference in cardiovascular events: any Study duration range 12‐96 months Omega‐6… compared with lower omega‐6: primary outcomes (low certainty).
1 finding from 1 review
CHD events · adults with or without existing CVD
It is very uncertain whether higher changes CHD events: myocardial infarction (fatal or non‐fatal) or angina… compared with lower omega‐6: primary outcomes (very low certainty).
1 finding from 1 review
MACCEs Study duration range 24‐96 months Omega‐6 dose range 2.8%‐12.0% E · adults with or without existing CVD
It is very uncertain whether higher changes MACCEs Study duration range 24‐96 months Omega‐6 dose range… compared with lower omega‐6: primary outcomes (very low certainty).
1 finding from 1 review
Fatal or nonfatal stroke · adults with or without existing CVD
It is very uncertain whether higher changes stroke: fatal or non‐fatal Study duration range 24‐96 months Omega‐6… compared with lower omega‐6: primary outcomes (very low certainty).
1 finding from 1 review
MI Study duration range 12‐96 months Omega‐6 dose range 2.8%‐24.5% E · adults with or without existing CVD
Higher showed no clear difference in MI Study duration range 12‐96 months Omega‐6 dose range 2.8%‐24.5% E compared with lower omega‐6: additional key outcomes (low certainty).
1 finding from 1 review
Serum TC Study duration range 12‐96 months Omega‐6 dose range 2.0%‐24.5% E · adults with or without existing CVD
1 finding from 1 review
Serum TG Study duration range 12‐72 months Omega‐6 dose range 2.0%‐15.0% E · adults with or without existing CVD
1 finding from 1 review
Proportion of participants developing a new pressure ulcer · people with spinal cord injury receiving rehabilitation treatment for the first time
It is very uncertain whether transmural care changes pressure ulcer incidence rate compared with usual follow‐up care (very low certainty).
1 finding from 1 review
Adverse events: readmission to clinical rehabilitation · people with spinal cord injury receiving rehabilitation treatment for the first time
It is very uncertain whether transmural care changes adverse events: readmission to clinical rehabilitation compared with usual follow‐up care (very low certainty).
1 finding from 1 review
Food intake · cancer cachexia in adults
1 finding from 1 review
Weight (kg) · cancer cachexia in adults
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Adverse events · cancer cachexia in adults
1 finding from 1 review